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Borrelia burgdorferi infection, aka Lyme disease, is one of the most prevalent vector borne 
illnesses in the world. With an estimated 300,000 infections per year in the United States alone, 
this pathogen places a large burden on the health care system, as well as causing debilitating 
symptoms in the individuals who are not adequately treated for the disease in a prompt manner. 
While the normal life cycle is based upon transmission by ticks from small mammals to large 
mammals, mainly deer, human infection results in a dead end for Borrelia. The maintenance of 
this life cycle is a key feature of Borrelia, and understanding its ability to live in two contrasting 
environments gives researchers a framework for understanding the disease.  
Genes for bacterial lipoproteins (lipid modified proteins) make up a large portion of Borrelia 
species’ genomes and play important role in the infection/transmission cycle. While lipoprotein 
modification and localization is understood in several bacterial species, such as Escherichia coli 
and Bacillus subtilis, a few key components of the lipoprotein localization pathway are missing in 
Borrelia. Furthermore, the signals involved in proper lipoprotein sorting are less clear than in other 
species.  Based on earlier studies in the laboratory, there are two proposed pathway components 
that are missing from a minimally functioning lipoprotein sorting machinery in Borrelia: a 
lipoprotein chaperone, which stabilizes the newly translocated lipoprotein in the outer membrane, 
and a lipoprotein “flippase”, which allows lipoproteins to pass through the outer membrane to the 
surface. To facilitate identification of these two hypothetical pathway components in functional 
screens, we embarked on two approaches. First, a mutational analysis of the complement binding 
protein CspA was performed with the aim to generate a subsurface mutant of CspA. CspA is a 
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complement factor H binding protein that renders the bacteria serum-resistant. The resulting 
subsurface mutant would provide a basis for a functional suppressor screen, selecting for pathway 
mutants that are capable of transporting the mutant CspA to the surface.  Additionally, the analysis 
would reveal the amino acids involved in localization of this lipoprotein, adding to the existing 
dataset with other Borrelia lipoproteins. In a parallel secondary approach, two separate binding 
proteins (Calmodulin and LysM) were setup to bind their respective targets (Calmodulin Binding 
Peptide and peptidoglycan) within the periplasm of B. burgdorferi, in an effort to stall the 
localization process. 
Based on our earlier work with Borrelia surface lipoproteins, a series of deletions within the 
intrinsically disordered N-terminal CspA tether were generated.  Deletions of both the first and 
second halves of the tether peptide in CspA failed to yield a subsurface phenotype. Starting with a 
second-half tether deletion, escalating stepwise 4-amino acid deletions in an N-terminal direction 
were made. Still, no subsurface CspA mutant was recovered, with the first 4 CspA tether amino 
acids still supporting the lipoprotein’s surface exposure. Additionally tether swapping with a 
subsurface localizing lipoprotein tether yielded no subsurface CspA. Second, two protein trapping 
methods were attempted. These were designed to stall the interaction between pathway 
components and lipoproteins inside of the periplasm. The introduction into the bacterial periplasm 
of the mammalian binding protein Calmodulin and surface sorting lipoprotein fused to a tag 
derived from a Calmodulin Binding Peptide yielded no transformants in single or multiple plasmid 
systems. Plasmids encoding for each of the individual components could be readily transformed 
separately. Alternatively, introduction of a fusion protein that links a surface red fluorescent 
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protein reporter lipoprotein to a native peptidoglycan binding peptide tag yielded significant 
filamentous growth as well as overall growth defects in E. coli, and no B. burgdorferi 
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1. Lyme Disease 
Since their discovery in 1905, spirochetes have been prominent pathogens in the field of human 
health (Tampa et al, 2014). The venereal disease syphilis, caused by Treponema pallidum, at the 
time changed marriage laws by requiring a blood test prior to applying for a marriage license 
(Quetal, 1990).  Another spirochetal genus, Leptospira, causes leptospirosis (i.e. Weil’s disease, 
black jaundice) and is one of the most prominent infections across the globe, with an estimated 
14 cases per 100,000 people infected per year (Haake and Levett, 2015). Due to advances in 
medicine, Treponema pallidum is easily treatable with antibiotics and easily preventable using 
safe sex practices. Although quite deadly if not diagnosed soon enough, antibiotics and sanitary 
living conditions can prevent diseases caused by Leptospira.  
While syphilis and leptospirosis have been known for more than a century, another spirochetal 
disease discovered in Lyme, Connecticut has been emerging as a widespread human health 
concern. Commonly referred to as Lyme disease, the disease is caused by infection with Borrelia 
burgdorferi (Burgdorfer, Barbour, et al, 1982). Since being discovered in 1976 due to an outbreak 
of misdiagnosed juvenile arthritis, the disease has grown from relative obscurity to being the most 
common vector borne illness in Europe and North America (Mead, 2015) with an estimated 
300,000 cases per year in the United States alone (CDC, 2014). The clinical manifestations of 
Lyme borreliosis have been documented well before the link to the spirochete was discovered: 
Afzelius describing erythema migrans, a growing target shaped rash, (Afzelius, 1921) and Garin 
and Bujadoux describing neurological symptoms after a tick bite (Garin and Bujadoux, 1922). 
However, the link between the neurological and accompanying symptoms associated with the 
cases described by Garin and Bujadoux and Borrelia have been recently called into question 
(Wormser and Wormser, 2016).  
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Due of the meteoric rise of Lyme disease cases in only 40 years, and the difficulty in correctly 
diagnosing the disease, there are a number of misconceptions about Lyme disease in the public. 
Many of these misconceptions are based on how B. burgdorferi is able to cause a persistent 
infection. This misconception is birthed from the symptoms of Lyme disease potentially lasting 
years after elimination of the pathogen. Whether or not the continuing symptoms are caused by a 
continuing infection or damage caused by the prior infection has been hotly debated amongst 
medical professionals (Halperin, 2015). When diagnosed early, a course of antibiotics can 
completely cure the bacterial infection with no sign of continuing symptoms (Steere et al, 1994). 
However, if misdiagnosed or undetected, the disease can successfully evade the immune system 
using a series of genetic programs that allow for antigenic variation of a lipoprotein (a type of post-
translational lipid modification) (Zhang et al, 1997) (Norris, 2014) as well as complement evading 
proteins known as CRASPs (Kraiczy et al, 2001).Without appropriate treatment Borrelia 
burgdorferi will continue causing Lyme disease and set up a persistent infection. Continuing 
infection will include symptoms of arthritis, malaise, fatigue, neurologic impairments, and in 
severe cases endocarditis (Steere et al, 1977). Upon diagnosis of Lyme borreliosis, treatment of 
the patient with penicillin or doxycycline will ensure the bacteria are eliminated from the body 
(Nocton et al, 1994). Antibiotic resistant Lyme disease is rare (Steere et al, 2004).  A recent study 
confirming the existence of drug-tolerant Borrelia in humans found that these “persister” cells 
were not antibiotic resistant and had not acquired heritable antibiotic resistance traits. These drug-
tolerant Borrelia are not replicating or metabolically active and are found to be morphologically 
distinct from log phase Borrelia (Sharma et al, 2015). This study establishes that B. burgdorferi 




Figure 1. Lyme Disease. Borrelia burgdoferi is the causative agent of the tick transmitted illness known 
as Lyme disease, or Lyme borreliosis. The major carrier of Borrelia Burgdorferi is Ixodes Scapularis 
which has a natural range that covers the majority of the eastern United States. Since its description in 
1982 the number of reported Lyme disease cases has grown to over 30,000 cases per year with estimated 
cases rising to over 300,000 cases per year according to CDC reports. While not all symptoms are present 
in every case of Lyme disease, common symptoms include a growing target shaped rash called erythema 




formation of persister cells does not lead to chronic illness in healthy patients due to immune 
clearance, but immunocompromised individuals are at risk for chronic Borrelia burgdorferi 
infection. Approximately 10% of US cases continue to suffer from arthritis after resolution of the 
infection due to damage already done during the infection (Steere, 1987). Additionally other 
persistent, co-infective, tick-borne pathogens as well as the detrimental effects of a course of broad 
spectrum antibiotics can continue past clearance of the bacteria (Ettestad, 1994). There are 
currently no vaccines available to humans for Lyme disease although there is at least one in the 
later stages of development (Comstedt, 2014).  
2. Life Cycle 
Although most notable for causing human Lyme borreliosis, Borrelia burgdorferi evolved separate 
from human interaction and has become completely dependent on the life cycle of ticks in the 
Ixodes genus (Kurtenbach, 2002). Borrelia starts the cycle in a reservoir species. Reservoir species                
are organisms which can carry a pathogen with little to no detriment to themselves or their 
reproduction, and can also be a site for multiple vector transmissions without detrimental immune 
surveillance (Donahue, 1987). The reservoir species for B. burgdorferi are typically smaller 
animals including rodents, lizards, and birds that are available for the larval form of Ixodes ticks 
to gain access to a blood meal (Steere et al, 2004). It has been proposed that birds are responsible 
for the quick dissemination of the disease over the past 40 years from strictly in New England to 
being found in half of the United States, although the reduction of farmland and increase in 
predator-less habitat in deer (Steere, 1994) is also hypothesized play a role in the increased 
geographic scope of the disease. Since Ixodes spp. are not specific in their host range, there are a 
large number of dead end hosts for B. burgdorferi (Margos, 2011). For B. burgdorferi, dead end 






Figure 2. Tick Enzoonotic Cycle. The Ixodes tick will undergo three blood meals in its lifecycle. Each 
blood meal will support either a transformation from larvae to nymphs to adults, or begin the reproductive 
cycle. Unlike relapsing fever and other tick-borne diseases, Borrelia burgdorferi is not transmitted 
transovarially (Rollend et al, 2013) and the larvae are born uninfected. Borrelia is acquired from an 
infected reservoir host during larval feeding. In the early summer larva is hatched and attempts to take its 
first blood meal in the late summer. Upon feeding the tick will drop to the ground and overwinter until 
May. As the larva is molting, the spirochete waits the long months until the nymph can undergo feeding. 
Once molted, the nymph has a much larger feeding range that still includes Borrelia’s reservoir species 
but also includes the dead end hosts including human. The nymph tick will attempt to take a blood meal 
in the late spring/early summer. If successful fed nymph will then grow into an adult over the next winter 
and reproduction will occur on a deer the following spring (Anderson and Magnarelli, 1980).  
  
Uninfected tick larva feeds on 
infected reservoir host. 
Infected tick larva molts and 
becomes a flat, or unfed, nymph. 
Infected nymph takes 
blood meal on a new host, 
Tick molts into an 
unfed adult tick. 
 
 Uninfected tick larva feeds on 
infected reservoir host. 
Adult ticks feed and 
reproduce on the final host 
.animal 
Borrelia burgdorfer is unable to be 




pathogen back to the tick (humans fall in this category), or are animals which have a bolstered 
immune defense to the pathogen (Radolf et al, 2012). Given that Ixodes has such a large host range 
and are able to host a large range of pathogens from viruses to fungi to bacteria to protozoa, the 
tick-Borrelia interaction plays a large role in the progress of the disease (Jongegan and Uilenberg, 
2004). 
2.1. Tick Uptake, Survival and Transmission 
Then a pathogen enters the tick through the mouth during a blood meal, the goal of the pathogen 
is to survive in the tick environment until retransmission. While in the midgut, ovaries, hemocoel, 
salivary glands or other immune deficient locations, the pathogen awaits until another blood meal 
can be taken and can be expelled through the salivary glands or until reproduction occurs and the 
pathogen is transmitted transovarially (Hajdusek et al, 2013). While theoretically the pathogen 
could move to any and all of these locations, as determined by their migration abilities and ability 
to deal with the tick immune system, the most likely place for a pathogen to reside is in the midgut 
of the tick. The midgut has limited digestive capabilities, an abundance of nutrients, and redox 
balancing agents that not only allows for commensal bacteria to live, but also for pathogens such 
as B. burgdorferi to survive the months between feedings (Hajdusek et al, 2013). While the midgut 
is a favorable environment for organisms in which to dwell, there are still challenges to overcome. 
Ticks do have antimicrobial peptides, hemocidins, and defensins to keep microbes from 
overrunning the midgut (Kopacek et al, 2010). However, these compounds are not species specific 
attacks, but generalized against Gram (+) and Gram (-) bacteria to which the tick-borne pathogens 
and commensal organisms have found defenses or avoidance measures. Borrelia are neither 
classified as Gram (+) or Gram (-), but are classified as diderms (Aberer and Durray, 1991). During 




Figure 3. Borrelia Genetic Control. Borrelia burgdorferi must survive in two very different 
environments and the transitions between them. To start Borrelia must protect itself from the threats of 
the reservoir species, typically a rodent, but it can also be found in birds and lizards. When the unifected 
tick takes a blood meal Borrelia will activate its tick phase genes in response to the saliva secreted by the 
tick. As Borrelia makes its way into the tick midgut, the tick environment will trigger the necessary genes 
for Borrelia to survive the coming months as the nutrients from the blood are depleted and mammalian 
phase genes are slowly turned off. After the tick molts into the nymph another blood meal will be taken. 
Borrelia will activate its mammalian-phase genes in response to heat and blood components/nutrients. 
This will cause and increase in proliferation and cause the migration of Borrelia to the new host.  
  
Tick-phase genes: Off 
Mammalian-phase genes: On  
Tick-phase genes: On 
Mammalian-phase genes: Off  
Tick-phase genes: On 
Mammalian-phase genes: Decreasing 
Tick-phase genes: Decreasing 
Mammalian-phase genes: On 
Uninfected Tick Larva 
 Reservoir Host 
Fed Tick Larva 
Flat Nymph 
Fed Nymph: 24-48 Hrs. 
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genetic switches to survive within the midgut of the tick. These changes in gene expression allow 
the bacteria to survive in three different environments within the tick (fed, fasted, and transmitting) 
as well as the mammalian host environment (Tsao, 2009). 
2.1.1. Acquisition and Replication 
When the tick bites the reservoir host, the tick’s salivary glands will release a number of pro-
inflammatory factors, anticoagulants, and antimicrobial peptides into the host (Hajdusek et al, 
2013). This allows blood to flow freely from host to tick. It is not completely known which factors 
play a role in Borrelial migration to the tick bite, but there is evidence that the uptake of Borrelia 
is not completely random (Moriarty et al, 2008). Borrelia can be detected in the tick after 24 hours 
before significant amounts of blood have been imbibed (Radolf et al, 2012). As the blood meal is 
being taken, the B. burgdorferi lipoprotein Bbe31 interacts with the tick protein Tre31 to 
disseminate from the mouth of the tick throughout the intestinal tract (Zhang et al, 2011). Entering 
the digestive tract, Borrelia must face the challenge of adhering to the midgut and preventing 
movement to the harsh environment of the hemocoel (Hajdusek et al, 2013). This is solved by the 
lipoprotein OspA binding to the midgut protein TROSPA (Target Receptor of OspA), allowing 
Borrelia to stay and compete for nutrients with the host (De Silva et al, 1996) (Pal et al, 2000). 
OspA, while highly immunogenic, also serves as a protective agent against antibodies. OspA is 
primarily expressed inside the tick vector, suggesting that the protection offered by OspA is only 
useful in the absence immune surveillance, although OspA may have a mammalian function as it 
is expressed in the late mammalian phase (Tilly et al, 2016). Once established in the tick, Borrelia 
uses the available resources from the blood to replicate (Li et al, 2007) while the changed 
environment triggers the activation of tick phase genes (Caimano et al, 2011). To deal with the 
changing nutritional and metabolic needs of the tick vector, B. burgdorferi must change the genes 
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transcribed and transcribed to better fit their metabolic needs and adapt to their environment. These 
genes are controlled in response to lowered nutrient levels by metabolic regulatory cascades. The 
histidine kinase cascade Hk1-Rrp1 responds to lowered nutrient levels and makes c-di-GMP 
(Kostick et al, 2011). In addition, the SpoT/RelA homologue Relbbu regulates (p)ppGpp levels in 
response to lowered nutrients (Drecktrah et al, 2015). The buildup of c-di-GMP as well as 
(p)ppGpp levels leads to the activation and transcription of tick phase promoters and sigma factors. 
The transcription and translation of tick phase genes allow the bacteria to survive for an extended 
period of time with limited nutrients as the tick proceeds through its life cycle to become a flat 
nymph.  
2.1.2 Survival 
As the Ixodes larva finishes its blood meal, it will drop from the primary host to the ground and 
molt into a nymph over the course of a few months. After only a few weeks the nutrients in the 
tick are depleted and Borrelia must wait out the winter in the low nutrient environment of the 
unfed nymph. Borrelia burgdoferi must lower its nutritional requirements as well as scavenge any 
nutrients that are available in order to survive. In this environment B. burgdorferi will stop 
replication and become extremely sluggish in its movement (Pal, 2010), but it does not become 
dormant and stop all transcriptional and translational activities (Dunham-Ems et al, 2009). Certain 
tick phase genes are still expressed in relatively high numbers. During starvation, the genes 
associated with glycerol metabolism are up regulated to provide a carbon and energy source for 
Borrelia (Pappas et al, 2011). The oligopeptide transporter oppA is also up-regulated, under the 
control of Relbbu, to provide amino acids because Borrelia is incapable of synthesizing them 




Figure 4. Signaling Pathways. Genetic control of Borrelia burgdorferi is dependent on the use of master 
regulator sigma factors that are regulated by the environment they are currently living in. Low amino 
acids induce tick phase genes through the metabolic enzyme RELBbu which makes (p)ppGpp. A yet 
undiscovered stimulus is responsible for activating tick phase genes through the creation of cyclic di-
GMP by phosphorylated Rrp1. High temperature, presence of blood, and nutrients lead to the up 
regulation of sigma factors RpoS and RpoD through the Rrp2/RpoN pathway, which control the 




Borrelia changes to increase interaction with the extracellular matrix (Drektrah et al, 2015). While 
there have been micro arrays performed in similar conditions to the unfed tick, many of the genes 
that are affected by starvation have an unknown function. This makes understanding Borrelia’s 
ability to survive in such conditions difficult (Pal, 2010). 
2.1.3.  Transmission to Host 
Once the infected tick has molted and matured to the nymph from, it seeks another blood meal. 
The tick now has a larger host range due to increased size and can deliver Borrelia to a wider range 
of species. This explains why nymph ticks transmit the majority of the disease involved in human 
cases (Tilly et al, 2008). As the tick begins to engorge itself on the new host’s blood, Borrelia must 
now defend itself from a number of threats inside the blood, scavenge as many nutrients as it can, 
and make its way from the midgut to the salivary glands to be excreted into the new host. The 
change in temperature from being on a warm-blooded host activates the Rrp2–RpoN–RpoS 
pathway as well as the sigma factor RpoD to prepare Borrelia for the mammalian phase of 
infection as well as repress tick phase genes (Ojaimi et al, 2003, Radolf et al, 2012). Rrp2, which 
is activated by autophosphorylation in the presence of acetyl phosphate, mediates the opening of 
the rpoS promoter and activates the sigma factor RpoN. This Rrp2-RpoN complex then activates 
the transcription of rpoS, which, when translated, acts as an alternative sigma factor during the 
mammalian host phase (Hu et al, 2010). Temperature, the presence of blood nutrients, and blood 
immune factors seem to be required for the complete transcriptional switch from tick phase genes 
to mammalian phase genes (Tokarz et al, 2004). While it is known that Borrelia must move from 
the midgut to the salivary glands (Schwan et al, 1995) for eventual exit from the salivary gland 
into the mammalian host (De Silva and Fikrig, 1995), the mechanism of travel from the midgut to 
the salivary gland has yet to be determined. Once in the host, the bacteria are in a nutrient rich, yet 
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hostile, environment. Here they must successfully evade the immune system whilst awaiting 
another tick bite to propagate the species. Although adult ticks can be infected by and transmit 
Borrelia, the processes by which B. burgdorferi survives, replicates and is transmitted to a new 
host is very similar to the nymphal form. 
Among the proteins that are upregulated in response to blood are a family of proteins called 
Complement Regulator-Acquiring Surfacing Proteins (CRASPs). CRASPs are an important part 
of immune evasion and immune defense that Borrelia has evolved in order to persist within the 
fed tick and the mammalian hosts (Kraiczy et al, 2001). The surface lipoprotein CspA (CRASP-1) 
is highly expressed in the anticipation of this blood meal to defend itself from mammalian 
complement (Hammerschmidt et al, 2014). As the blood meal arrives, CspA dimers and the 
lipoprotein OspE independently bind to Factor H. The role of Factor H in mammals is to bind to 
normal “self” cells within the host to prevent autolysis using the Alternative Complement Pathway 
(Kraiczy, 2004) (Hellwage, 2001). When CspA binds to Factor H, the complement system will 
overlook Borrelia and prevent complement lysis. CspA also binds to complement components C7-
C9 making it difficult for the Membrane Attack Complex to form on the surface (Hammerschmidt 
et al, 2014). Recently, the lipoprotein BBK32 has been shown to bind the complement factor C1. 
Complement factor C1 is a part of the Classical Complement Pathway and is recruited by IgG and 
IgM antibodies to the binding site. BBK32 binds C1 and the C1r subunit to prevent antibody 
mediated lysis (Garcia et al, 2016). The ability of BBK32 to bind complement also demonstrates 
the ability for proteins to have multiple roles, as BBK32 was first identified as a fibronectin binding 
protein (Li et al, 2006).   
Lipoproteins such as OspC, CspA, OspE, and BBK32 are important in overcoming the innate 
immune system. OspC has been determined to prevent phagocytosis by macrophages, a crucial 
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step in passing through the first barrier of the skin (Carrasco, 2015).  The lipoprotein VlsE is a part 
of the antigenic variation system that allows Borrelia to avoid the adaptive immune response using 
random recombination events with silent gene cassettes. While each one of these variable surface 
proteins may or may not be antigenic, the randomization of the antigen throughout the mammalian 
life cycle gives the Borrelia infection as a group an advantage over the antibody response. It also 
continuously delays a detrimental immune response as the expressed protein is varied (Norris, 
2014). Along the same lines, Borrelia will vary the expression of the surface proteins VlsE, OspA 
and OspC in response to the host’s immune surveillance. Indeed, VlsE is expressed as OspC is 
downregulated, and OspC is produced only during early mammalian infection when OspA is 
downregulated (Ohnishi et al, 2001). Not only can Borrelia vary expression of proteins to avoid 
immune surveillance, but it can also modify the proteins themselves to achieve a greater level 
inconspicuousness (Tilly, 2016). Overall, these examples show that surface lipoproteins are crucial 
to the life cycle of Borrelia as it moves from host to tick and eventual return to mammalian host.  
3. Borrelia burgdorferi 
3.1.  Genome 
Borrelia burgdorferi has a uniquely structured, fragmented, and complex genome, especially 
considering its relatively small genome size. The main chromosome is linear, with covalently 
closed ends (telomeres), and approximately .91 megabases in length (Fraser et al, 1997). This 
linear main chromosome encodes for 846 predicted intact proteins, including the majority of 
metabolic proteins and all but one protein (encoded by the circular plasmid or “minichromosome” 
cp26) that is required for growth in culture.  Close to 70% of the proteins on the main chromosome 
have homologues with either known or unknown bacterial proteins, leaving approximately 250 
coding sequences that appear unique to Borrelia/Borrelia burgdorferi (Fraser et al, 1997). Like 
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the various other species that make up the Borrelia genus, B. burgdorferi carries a plethora of 
circular and linear plasmids (Barbour, 1988). As exemplified by the lipoproteins discussed above, 
these plasmids carry a variety of different genes required for various facets of the Borrelia life 
cycle. While each Borrelia species contains a highly similar chromosome, up to 93% nucleotide 
identity excluding the telomeric regions (Glockner, 2006), the plasmid content of these Borrelia 
species are highly variable in total number of plasmids and in the ratio of linear plasmids to circular 
plasmid. For the Borrelia burgdorferi sensu stricto laboratory strain B31, there are 12 linear 
plasmids and nine circular plasmids with a size range of 9 to 62 kilobases (Fraser et al, 1997). 
While most species of bacteria contain circular genomes and circular plasmids, Borrelia species’ 
genomes require telomeric ends to their linear DNA segments and behave more similarly to 
eukaryotic genomes in terms of replication and homeostasis. 
3.2. Metabolism 
The metabolism for Borrelia is very simple, which is expected considering the size of the genome. 
There are no genes for the TCA (Krebs) cycle, respiratory (electron transport) chain, or for nucleic 
and amino acid synthesis (Fraser et al, 1997). This makes the bacteria highly reliant on obtaining 
the basic requirements of life from the surrounding environment. For most bacteria the inability to 
synthesize some of the basic building blocks of life would be detrimental. However, because 
Borrelia’s life cycle has been adapted to the high nutrient environments it lives in, any ability to 
synthesize nutrients in such an environment would have been selected out in favor of increased 
scavenging abilities. While B. burgdorferi is an efficient scavenger of nutrients, a unique trait of 
Borrelia burgdorferi is the complete lack of the use of iron as a cofactor. While many bacteria 
engage in an iron scavenging war with their hosts using bactoferrins, Borrelia avoids this process 
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altogether (Posey and Gherardini, 2000). Instead it uses other divalent ions such as manganese 
(Troxell et al, 2012) and zinc (Nguyen et al, 2013). 
Another aspect of metabolism is an organism’s ability to break down the chemicals that other 
organisms employ as a defense mechanism. Many organisms employ a chemical defense that 
contains reactive oxygen species.  Without catalase, Borrelia is susceptible to oxidative stress, and 
is restricted to low oxygen concentrations as to avoid oxidative damage and excess free radicals 
(Fraser et al, 1997) although Borrelia does have a manganese based superoxide dismutase (Troxell 
et al, 2012). 
3.3.  Cell Structure 
B. burgdorferi is classified as a spirochete, but the bacterium is not actually spiraled in shape. 
While neither truly Gram positive or negative, the diderm rod that makes up Borrelia is a flat wave 
that gives the illusion of a spiraled corkscrew when in motion (Goldstein et al, 1994)(Gupta, 1998). 
Borrelia spp. stain weakly Gram-negative, but their lack of lipopolysaccharide (LPS) on the 
surface eliminates one of, if not the main marker for immune systems to recognize Gram (-) 
bacteria. Between the two lipid bilayers, a thin layer of peptidoglycan gives support to the cell, 
and bundles of flagellin give the cell its shape and ability to move (Charon et al, 2009) 
(Dombrowski et al, 2009).  
4. Bacterial Lipoproteins 
Lipoproteins are proteins that have been covalently modified post-translationally with a fatty acid 
moiety. Bacterial lipoproteins are found outside of the cytoplasm and can be located on either the 
periplasmic surface of the inner membrane, or on either side of the outer membrane of most 
bacteria (Wilson and Bernstein, 2015). Lipoproteins perform a wide variety of tasks from 
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providing envelope structure and stability, and aiding in cellular division, ATP transport, 
pheromone signaling, virulence, and immune evasion (Kovacs-Simon, 2011).  
4.1 Lipoprotein Usage 
As membrane-associated proteins, lipoproteins have some key advantages and disadvantages 
compared to their unlipidated integral membrane protein counterparts, which contain domains that 
span the entirety of the phospholipid bi-layer. Characteristically, the lipid bilayer moves very 
quickly in relation to the proteins that are associated with it. By peripherally anchoring the protein 
via a lipid moiety, the membrane remains more fluid, as compared to anchoring with integral 
membrane proteins. The presence of lipid rafts (slow moving protein and cholesterol dense regions 
of the lipid bilayer) is unique to Borrelia amongst bacterial species, and the use of cholesterol in 
their membranes is rare across the bacteria kingdom. The use of lipoproteins in lipid rafts and the 
preferential localization of lipoproteins to lipid rafts gives an order and structure to the outer 
membrane (Toledo et al, 2014). With over 120 lipoproteins, Borrelia membranes can remain 
flexible and can withstand the force of the flagellar machinery located in the periplasmic space 
(Dombrowski et al, 2009). Conversely, integral membrane can act as anchors that give structure 
and order to the membrane and bacteria as a whole (Kenedy et al, 2012). Lipoproteins bridge the 
gap between integral membrane proteins and amphipathic protein domains, which are very loosely 
associated with the membrane at a KD in the range of 190nM (Jensen et al, 2011), lipoproteins stay 
anchored with a KD of .54nM (Hu et al, 2015). This ensures that the protein remains at the 
membrane. Much of the work performed on lipoprotein modification, secretion and localization 




Figure 5. Lipoprotein Secretion Machinery. A) Upon export of the prolipoprotein via either the Sec or 
Tat machinery, the proliprotein will be lipidated, cleaved, and further lipidated by the lipidation 
machinery proteins Lgt, Lsp, and Lnt respectively. The Secretory complex (Sec) or Twin Arginine 
Transporter (TAT) are responsible for transporting proteins with a signal peptide and placing them in the 
innermembrane with the help of YidC. Once lipidated by Lnt, the newly completed lipoprotein must be 
properly localized. B) The Lol pathway is responsible for removing lipoproteins from the inner membrane 
to the outer membrane. D) The type II and E) type V secretion system directly translocates lipoproteins to 
the outer surface. The N. gonorrhea protein NalP is secreted through the type V secretion system and will 
autolytically cleave to become a part of the surrounding environment. The putative spirochete secretion 




4.2 Secretion, Cleavage and Lipidation (Fig. 5) 
Upon recognition of an export signal at the N-terminus of the nascent lipoprotein, a cytoplasmic 
chaperone will transport the newly synthesized prolipoprotein to the inner membrane. Once 
transferred to either the Sec or Tat machinery, which will export newly synthesized proteins and 
insert them into the cytosolic membrane (Froderberg et al, 2004, De Buck et al, 2004). As the 
protein is being exported, the lipidation machinery will recognize a 5-amino-acid motif (called a 
lipobox) at the C terminus of the export signal peptide (Wu, 1996).  The lipobox includes a 
conserved cysteine that will be modified with phosphatidylglycerol fatty acid group (Wu et al, 
1982). The identity of the amino acids that constitute the lipobox can vary. For E. coli the 
consensus lipobox is comprised of LLAGC while for Borrelia the consensus sequence is LLIAC 
(Haake, 2000). There is some variation in the first four amino acids of the lipobox, and the 
congruency of the sequence is greater in Gram negative and Gram positive bacteria than it is for 
spirochetes.  
Upon export and insertion of the prolipoprotein by either the Sec YEG or Tat pathway, a 
diacylglyceryl molecule is attached via the prolipoprotein diacylglyceryl transferase (Lgt) to the 
soon to be N-terminal cysteine (Tokunaga et al, 1982). Lgt has 7 transmembrane domains and 
performs its enzymatic activity within the cytoplasmic membrane (Pailler et al, 2012). 
Phosphatidylglycerol is the substrate of choice for this modification while 
phosphotidylethanolamine, phosphotidyl serine and cardiolipin are excluded from this reaction. 
The interaction between Lgt, the target lipoprotein, and phosphotidylglycerol has yet to be 
determined, but amino acids essential for Lgt function are located within the transmembrane 
domains (Pailler et al, 2012). Regarding the acyl chains, mass-spectrometry data of modified 
lipoproteins have suggested that there is little to no selection concerning which acyl chain is 
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attached to the prolipoprotein, and the lipid moiety percentages are based on the fatty acid 
composition ratios of the species of bacteria in question (Buddelmeijer, 2015). Since Borrelia 
acquires its fatty acids from the environment, logically the acyl chain modification would be 
dependent on the environment, although this has not been experimentally shown.  
Upon the addition of the diacylglyceryl moiety to the sulfhydryl group of the +1 cysteine, the 
export signal peptide is removed before the addition of another fatty acid to the amino nitrogen the 
“+1” cysteine (Tokunaga et al, 1984). This is performed by the prolipoprotein signal peptidase 
(Lsp) (Tokunaga, Loranger, Wu, 1983).  Lsp is a conserved aspartic protease that can be 
transferred among bacterial species readily and still function (Pragai et al, 1997). It has 4 
transmembrane segments and 6 required active site amino acid residues (Munoa et al, 1991). Lsp 
recognizes the signal peptide with the attached thio-acyl group, and as this thiolipid is required for 
the enzyme to recognize and bind the target prolipoprotein, the modification of the lipoprotein is 
ensured to proceed in a stepwise manner (Tokunaga et al, 1983).  Cleavage of the signal peptide 
can lead to other modifications of the newly released short peptide chain which can play a role in 
cell signaling in some bacteria (Cook and Federle, 2014). However, the usual endpoint for the 
signal peptide is degradation by a signal peptide peptidase (Pecaud, 1982). The “+1” cysteine 
residue is now the N-terminus of the apolipoprotein.  
Upon cleavage of the signal peptide the apolipoprotein will undergo further modification with two 
additional fatty acid chains. These acyl chains are attached to the amine nitrogen of the “+1” 
cysteine of the apolipoprotein (Gupta and Wu, 1991). This reaction is catalyzed by the 
apolipoprotein N-acetyltransferase (Lnt). In vitro, Lnt prefers to use phosphotidylethanolamine 
with 16-18 carbon acyl chains, but it can utilize other phospholipids with small polar head groups 





Figure 6. Lipoprotein Structure. As the nascent prolipoprotein is being synthesized in the cytoplasm the 
N-terminal signal sequence (purple and orange) will interact with a chaperone that will deliver the 
lipoprotein to the Sec or Tat pathway. Moving towards the C-terminus of the protein, the lipobox 
(orange and yellow) will signal the interaction between the +1 cysteine and lipid adding machinery of 
Lgt, Lsp and Lnt before the fully mature lipoprotein is localized to its final destination. A specific amino 
acid sequence following the +1 cysteine is responsible for the proper localization of the lipoprotein 
(green). Once properly located, the tether, a small unfolded region which includes the localization 
signals, separates the lipoprotein from the lipid bi-layer (green and blue). The functional domain (gold) 
of the lipoprotein is found at the C terminal end, and can be mostly unstructured or highly structured 





forming a thioester substitution intermediate with the acyl chain to be transferred. This creates an 
acyl-enzyme intermediate that will attach the acyl chain to the +1 cysteine to form a triacylated 
protein (Buddelmeijer and Young, 2010). For most bacteria the triacylated form is the mature 
lipoprotein. However, Borrelia seems to have a unique system in which one of the acyl chains 
from the thioglyceryl moiety is replaced with an acetyl group. This leaves a lipoprotein with only 
two fatty acid chains and an acetyl moiety as the mature form of lipoprotein (Beerman, 2000). 
4.3. Lipoprotein Sorting (Fig. 5) 
Once the lipoprotein has been fully modified and matured, it must now move to its final location. 
In E. coli the vast majority of lipoproteins are found on the inner leaflet of the outer membrane 
(Tokuda, 2007). In Gram-negative bacteria, lipoproteins are quite frequently used for membrane 
stability to balance the bulky lipopolysaccharide on the outer surface. The most abundant 
lipoprotein in E. coli, Lpp, is responsible for maintaining membrane stability and homeostasis 
(Suzuki et al, 1978). In more recent work Lpp has been shown to localize to two different cellular 
compartments dependent on binding of peptidoglycan. This limits Lpp’s ability to translocate to 
the outer membrane (Cowles et al, 2011). For bacteria without LPS, like Borrelia, the ratio of inner 
membrane:inner leaflet of the outer membrane:outer leaflet of the outer membrane are much 
different. Data from our own lab has place the ratios at 30%:5%:65% (Dowdell et al, 2017).  
If the mature lipoprotein has a final localization to the inner membrane, no further action is 
required for correct localization. However, since the majority of the lipoproteins by abundance and 
by number are in the inner leaflet of the outer membrane, outer membrane lipoproteins must be 
released from inner membrane (Tokuda, 2007). The Lipoprotein outer membrane localization 
(Lol) pathway is responsible for moving lipoproteins from the inner membrane to the outer 
membrane and is essential for survival of the bacterial cell. Discovered in 1995 and elucidated in 
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the following years, the Lol pathway is an important feature of the periplasmic space (Matsuyama 
et al, 1995). Composed of 5 proteins, the Lol pathway includes proteins in the cytoplasm, inner 
membrane, periplasm, as well as the inner leaflet of the outer membrane. The LolCDE complex is 
the ATP driven launching pad for LolA, which is the shuttle for the lipoprotein. LolB acts as a 
dock for the LolA-lipoprotein complex and inserts the lipoprotein into the outer membrane. 
Detailed pathway functions have been teased from the E. coli LolA pathway transporting Lpp and 
Pal. Upon acylation by Lnt, the LolCDE complex binds the mature lipoprotein (Yakushi et al, 
2000). First interacting with LolE, the lipoprotein is transferred from Lnt to LolE. This causes 
conformational changes in LolD which in turn binds ATP (Mizutani et al, 2013). Since removing 
lipids from the lipid bilayer is energetically unfavorable due to hydrophobic forces, cytoplasmic 
LolD provides the energy to overcome this unfavorable reaction. By converting ATP to ADP, 
LolD allows for the removal of the lipoprotein from the inner membrane and transfer of the 
lipoprotein from LolE to an unloaded LolC:LolA complex. Conformational changes caused by 
LolA’s binding to the lipoprotein releases LolA:lipoprotein from the LolCDE complex (Okuda 
and Tokuda, 2009). LolA then acts as the periplasmic chaperone that transports the lipoprotein 
across the periplasm to the outer membrane (Yakushi et al, 1998). LolB, already present on the 
inner surface of the outer membrane, receives the lipoprotein and inserts it into the outer membrane 
(Matsuyama et al, 1997). Both LolA and LolB bind the lipid moieties of the lipoproteins using a 
hydrophobic pocket that allows for interaction with the full range of lipoproteins. It has been 
suggested that due to the greater binding affinity of LolB than LolA to lipoproteins, the reaction 
flows from inner membrane to outer membrane, even though transfer from LolB to LolA is 




4.3.1 Sorting Signals 
Upon cleavage of the signal peptide, the now mature lipoprotein contains another signaling 
mechanism for the sorting of the lipoproteins. In E. coli, the +2 position is the determining amino 
acid localization in most cases. Aspartic acid in the +2 position retains the lipoprotein in the inner 
membrane while other amino acids such as serine in the +2 position allow for the movement of 
lipoproteins to the outer membrane (Yamaguchi et al, 1988). There is growing evidence that the 
+3 position influences the localization of lipoproteins in E. coli, and the +3 and +4 positions have 
been implicated in other gram negative bacteria as important residues for proper localization. 
(Lewenza, 1998).  
In the case of B. burgdorferi and some others, the Lol pathway is incomplete as there is no 
detectable LolB homolog (Okuda and Tokuda, 2011) (Zuckert, 2014). The sorting rules are also 
different in B. burgdoferi as many different amino acid residues are found in the +2 position of 
outer surface proteins (Schulze et al, 2010). Also missing from Borrelia are key components of 
the type II and type V secretion systems that place proteins on the outer surface of some Gram 
negative bacteria (Fraser et al, 1997) (Zückert, 2014). Work done in our lab has shown that 
mutations in the intrinsically disordered region between the lipidated cysteine and the folded 
protein (called the “tether”) can cause outer surface lipoproteins to mislocalize to the periplasmic 
face of the outer membrane (Kumru et al, 2011). Although the mechanism remains unclear, our 
hypothesis is that these mutants cause premature folding in the periplasm. This may possibly be 
due to lack of interaction with a putative periplasmic holding chaperone and the hypothesized 




5. Overall Goal 
The overall goal of this thesis project was to establish either a biochemical or genetic screen to 
identify key lipoprotein secretion pathway components in Borrelia burgdorferi.  The project also 
further explored potential spirochetal lipoprotein sorting signals. 
6. Approach (Fig. 7) 
To identify any sorting signals responsible for localizing lipoproteins to their respective locations, 
our lab has undertaken a series of mutational analyses of the intrinsically disordered “tether” region 
that lays between the lipidated cysteine anchor and the structured, functional fold of each 
lipoprotein (Figure 6). One potential function of the tether may be to provide the necessary distance 
between functional protein domains and the membrane (Zuckert, 2014), situating the protein 
optimally within the surface proteome. The tether regions for lipoproteins vary greatly in amino 
acid length. OspA has a 12-amino-acid tether while CspA has a 33-amino-acid tether. With 170 
amino acids, the longest unstructured tether in a B. burgdorferi lipoprotein belongs to BBA66 
(Brangulis et al, 2014).  The functions of these lipoproteins provide some insight that function may 
dictate form. OspA is both immunoprotective against antibodies and binds to a protein in the tick 
midgut which may favor a close, tight binding. CspA, however is an important anti-immune 
response protein (Hammerschmidt et al, 2014). Because of the randomly activating nature of the 
Alternative Complement Pathway, CspA may act as an extended shield, using factor H to prevent 
the further action of C3b in forming the membrane attack complex. Thus, the more extended the 
shield (the longer the tether), the more protection may be offered. The function of BBA66 is 
undetermined but it is important for transmission to the host (Patton et al, 2013). In previous work 
performed by our lab, we used deletion and mutagenesis of this tether region to create subsurface 




Figure 7. Approach. Two strategies taken to determine the periplasmic components involved in 
localizing lipoproteins, substrate trapping and mutation. In substrate trapping we attempt to use binding 
partners to physically hold the lipoprotein in the periplasm. This increases the number of lipoproteins 
bound to their interacting partners and allows for crosslinking methods to be employed. One method of 
substrate trapping attempted was the use of a lipoprotein calmodulin binding to a OspA:CBP fusion 
stopping the secretion at the inner surface of the outer membrane. Another method involves the 
interaction between LysM and peptidoglycan (PG). Using the native OspA tether fused to an RFP marker 
and a native LysM domain, the protein should be located in the periplasm. CspA is a serum protective 
lipoprotein that binds to Factor H and prevents lysis by complements Membrane Attack Complex. If a 
subsurface CspA could be created, the membrane would become susceptible to lysis by human serum. A 





6.1. CspA Mutational Analysis 
As mentioned above, CspA is an important gene in the life cycle of Borrelia because it offers 
protection from complement. While understanding which amino acid combinations in the tether 
produce surface, subsurface and inner membrane mutants was one of the secondary goals of this 
study, the creation of a subsurface CspA through tether mutation would allow for a suppressor 
screen to be run. Because a subsurface CspA mutant would be vulnerable to lysis by complement, 
Borrelia would be unable to survive in a complement rich media. Any mutation that causes 
restoration of the mutant lipoprotein’s localization to the surface (i.e., any additional mutation that 
suppresses the original mutant phenotype) would confer protection to the bacteria and allow them 
to grow in the presence of complement. Reversion can occur in two ways: a compensatory 
mutation in CspA that allows for CspA to pass to the surface, or a mutation in any lipoprotein 
secretion pathway protein that causes the subsurface mutant CspA to be exported to the surface in 
spite of its subsurface localization signal. Reversion mutants of CspA can reveal more about the 
amino acid sequence signals required for export, and mutations in other proteins lead to a greater 
understanding of the export pathway components. Creation of the subsurface mutants was 
attempted in a two-fold approach. The primary approach was to isolate the necessary component 
of the export signal within the CspA tether through mutational analysis. A secondary approach 
was to fuse CspA with a previously known subsurface lipoprotein tether. 
6.2. Periplasmic Trapping of Lipoproteins 
While we have a full complement of his-tagged lipoproteins as well as antibodies to a wide array 
of lipoproteins that localize to the three residencies of lipoproteins, co-immunoprecipitation of 
these proteins has not resulted in the identification of lipoprotein pathway components by MudPIT 
mass spectrometry. Processing and transport of these proteins appears to be fairly quick, and 
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therefore the majority of surface and subsurface lipoproteins are in their final locations at steady 
state. This means the process must be slowed down or stalled, similar to work done with VSV viral 
infection in Eukaryotic systems to study protein export and localization in the Golgi. (Miranov et 
al, 2001). We attempted to physically stall protein movement through the mutational addition of 
known protein binding domains of calmodulin and LysM. 
6.2.1. Calmodulin 
Calmodulin is a small, highly conserved eukaryotic protein that changes conformation in the 
presence of Ca2+, causing the protein to interact with other proteins via a calmodulin binding 
domain (CBD). This conditional binding can be exploited, e.g., in protein purification protocols, 
by using a high-affinity recombinant calmodulin binding peptide (CBP) (Egorov et al, 2004).  Our 
lab has used another feature of calmodulin to show that the unfolding of the proteins in necessary 
for secretion to the outer surface by manipulating Ca2+ levels in the media (Chen and Zuckert, 
2011). By inserting a CBP onto a peptide that normally localizes to the bacterial surface and 
introducing a calmodulin that localizes to the periplasm we hypothesized that the lipoprotein:CBP 
fusion would be stalled in the periplasm with any associated transport proteins. In these 
experiments, we used OspA as a model surface lipoprotein with both a C-terminal and N-terminal 
CBP tag.  
6.2.2. LysM 
The LysM protein domain is a GlcNAc binding domain that is used by multiple proteins in all 
kingdoms. Peptidoglycan contains long chains of GlcNAc, and LysM domains are frequently used 
to anchor proteins to the bacterial cell wall with some proteins containing multiple LysM domains 
(Mesnage et al, 2014). Work done in S. aureus has shown that the LysM domain can be used to 
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hinder the progression of protein excretion when attached to proteins (Ebner et al, 2015). In this 
study we used multiple repeating LysM domains in an attempt to anchor a wild type OspA 
tether:mRFP fusion to the periplasmic peptidoglycan. 
7.  Results 
7.1. Generating a Subsurface CspA Mutant 
A series of CspA deletion mutants were created using overlap extension PCR to find the minimum 
amino acid tether sequence required to locate CspA to the surface. Cysteine 25 represents the N-
terminus of the mature CspA lipoprotein and the end of the lipobox. Data from previous 
experiments showed that both a deletion of amino acids 26-45 and 46-63 amino acids did not 
prevent surface localization in B. burgdorferi. That experiment was repeated here and is shown in 
Figure 8.  Further deletions, in 4 amino acid increments, were made to extend the deleted tether 
portions towards the N-terminus, continuing from the available Δ46-63 mutant (see Table 2 for 
oligonucleotide primers). The mutants’ localizations were tested using a standard protease 
accessibility assay, incubating with Proteinase K at a final concentration of 200 µg/mL for an hour 
at room temperature. Proteinase K will degrade any accessible proteins at the surface of the 
bacterial cell membrane. While this can cause membrane instability, great care is taken to ensure 
that the membrane remains uncompromised and does not allow Proteinase K access to the 
periplasm or the cytoplasm. These methods include gentle buffers and slow centrifugation speeds. 
Whole cell lysates were separated on a SDS PAGE, normalized for total protein amount, and 
analyzed by Coomassie staining and western blotting with protein-specific antibodies.  
After analysis, all CspA tether deletions remained localized to the surface, including the amino 
acid 30-63 deletion which did not bind the available monoclonal anti-CspA antibodies. This Δ30-
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63 mutant was clearly shown in the Coomassie stain as sensitive to proteinase K (Figure 8), but 
the mapped CspA epitope lay just past the tether region (Kraicsy et al, 2004) which could be 
important for proper folding of the protein. To get around the limitation in analyzing this Δ30-63 
mutant, a poly-histidine tag was placed on the C-terminus of the mutant protein to help determine 
its localization. Yet, the protein remained undetectable by a His-probe or by an anti-poly-histidine 
antibody (Figure 8). One thought is that a peptidase could be responsible for cleaving the his-tag 
from the C-terminus. 
In previous studies, we generated subsurface tether mutants of the surface lipoprotein OspA 
(Schulze and Zuckert, 2010). Thus, in an alternative approach, we fused a wild type surface OspA 
tether and the tether of a subsurface mutant OspA to the functional fold of CspA. Neither the wild 
type or mutant OspA tether:CspA fusions were detectable through CspA antibodies or through 
histidine antibodies after the addition of a C-terminal histidine tag (Figure 8). Yet, Coomassie 
staining showed that a band matching the size of both the OspA tether:CspA fusions were degraded 





Figure 8.  CspA Mutations. A) CspA tether deletions, indicated by Δ#-#, and mutations, described 
below, were made to attempt to create a subsurface CspA to be used in a suppressor screen. The 
mutations were made in a systematic manner to determine the minimum required tether for correct 
localization. In addition to deletions, a subsurface mutant tether from OspA ΔV21 (Schulze et al, 2010) as 
well as a WT OspA tether control were added as a failsafe to ensure a subsurface localization. B) 
Proteinase K (PK) will digest only surface proteins of cells with intact membranes. Wild type CspA is 
found on the surface of Borrelia during the mammalian phase, and the corresponding band disappears 
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after an hour of treatment with proteinase K at 200µg/mL indicating that the protein is on the surface.  
After PK treatment, no tether deletions or mutations were found to be subsurface either by western blot 
and antibody staining or by Coomassie staining (shown) including the OspA subsurface tether.   
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7.2. OspA Fusions to Calmodulin-Binding Peptide 
Using Gibson assembly (New England Biolabs), a calmodulin binding peptide (CBP) was 
introduced to OspA. Two CBP:OspA fusions were made, one at the OspA C-terminus and one at 
the N-terminal end between the tether and functional fold. Upon proteinase K treatment both C-
terminal and N-terminal fusions were determined to be localized at the surface of B31e2, a high 
passage strain of B. burgdorferi (Figure 9a). With the confirmation of normal localization for both 
the C-terminal and N-terminal CBP fusions, we took two approaches to introduce calmodulin into 
the OspA:CBP system. First, the recombinant plasmid already expressing the OspA:CBP fusion 
was modified by adding a module expressing an outer membrane-anchored, periplasmic 
calmodulin under a tetracycline-responsive promoter (Post, Whetstine et al, 2009). The resulting 
plasmid was used to transform E. coli, and the correct sequence was confirmed by single-pass 
sequencing (ACTG, Inc.) Induction of expression of calmodulin by addition of 
anhydrotetracycline in E. coli was also confirmed (Figure 9b). Yet, no transformants of high 
passage B. burgdorferi strain B31 clones B31e2 or B313 were ever recovered. Since the vector 
carrying both calmodulin and the OspA:CBP fusions were approximately 10kb in size, which may 
affect the transformation efficiency for Borrelia, we decided to take a two-plasmid approach. In 
this second approach, a suicide plasmid (Figure 9b), unable to replicate in B. burgdorferi, was 
designed to place the tetracycline-inducible subsurface calmodulin module on the main 
chromosome via homologous recombination. The suicide plasmid was constructed without any 
replication or growth defects in E. coli. In addition to electroporation with the circular suicide 
plasmid, the plasmid was cleaved with a single cutting restriction enzyme (Acc1) to create a non-





Figure 9. OspA Mutations. A) Creation of OspA mutants to include a short peptide binding site for 
calmodulin. The addition of the CBP at either the N-terminus or C-terminus had no effect on the 
lipoproteins ability to localize to the surface as shown by proteinase K treatment for 1 hour. B) A suicide 
plasmid containing an anhydrotetracycline (TetR) inducible calmodulin (CaM) and an CBP:OspA fusion 
was able to vary expression of CaM in the presence of anhydrotetracycline in E. coli, but no clones either 
via single plasmid (with the CBP OspA) or homologous recombination (TetR:CaM only) were ever 








Neither the linear nor the circular forms of the suicide plasmid yielded transformants in B. 
burgdorferi strains B31e2 and B313. 
7.3.  Fusion of a B. burgdorferi LysM Domain to a OspA28:mRFP Fusion 
The LysM domain belonging to the B. burgdorferi gene BB0323 was fused to a red-fluorescent 
lipoprotein that localizes to the bacterial surface using the wild-type OspA tether 
(OspA28:mRFP∆4; Schulze and Zuckert, 2010). The OspA:mRFP:LysM fusion was placed under 
the control of the constitutive B. burgdorferi flaB promoter. We hypothesized that upon addition 
of the LysM domain to the C-terminal end of the fluorescent lipoprotein, the fusion protein would 
bind periplasmic peptidoglycan and, thus, be blocked from localizing to the surface. Although the 
E. coli transformants did fluoresce red (Figure 10D), the bacteria had noticeable divisional defects 
and their growth rate was significantly lower (Figure 10ABD). Additionally, DNA extraction 
yielded poor amounts of low quality plasmid. Thus, upon electroporation, no Borrelia 
transformants of clone B313 were recovered either due to poor yield or toxicity of the plasmid.  
8. Discussion 
Results from our previous studies have suggested that the default pathway for lipoproteins in 
Borrelia leads them to the surface. This means that a form of retaining signal is required to prevent 
movement across the periplasm and movement to the surface (Schulze and Zuckert, 2006). One 
can imagine any number of scenarios in which lipoproteins interact with transport chaperones, 
folding chaperones, flippases, proteases, and modification enzymes that all play some role in 
moving lipoproteins to their predetermined location. Due to the fact that the majority of lipoprotein 
species are already in their final location (i.e., not bound by localization machinery), whether that 





Figure 9. LysM Toxicity. A surface localizing mRFP fused to LysM was created to bind a lipoprotein to 
peptidoglycan (gene schematic shown above, colors as in Fig. 6). A) and B) The plasmid containing the 
LysM fusion proved to inhibit growth in E. coli upon transformation in optical density at 600nm (A)) as 
well as visual inspection (B)) compared to the control vector pRJS1009. No positive tranformants were 
ever recovered in high passage Borrelia strains B313 or B31e2. C) While a vector with just mRfp and no 
LysM domain caused no growth defect, D) E. coli containing the LysM domain with mRfp showed 






surface of Borrelia, it is difficult to study the system with the limited number of proteins in the 
state of transport (i.e., bound by the localization machinery). Earlier crosslinking analyses in our 
lab using lipoproteins as baits have not identified the pathway components. This study’s attempts 
to interfere with transport of lipoproteins have proven to be deleterious, at least under the 
conditions tested. While surface localization may be the default pathway for lipoproteins in 
Borrelia, there continues to be a need for a biochemical interaction with the components moving 
through the pathway. In Gram-negative bacteria, such as E. coli or Pseudomonas, there is clear 
signaling in the +2 through +4 amino acids that determine localization, with little variance. In 
Borrelia, the +2 through +4 amino acids are highly variable (Setubal et al, 2006). As this study 
has suggested, the requirement of the CspA tether to localize to the surface is less than its 
requirement for it to fold correctly. Additionally, a mutant tether that causes OspA to mis-localize 
to the inner leaflet of the outer membrane does not restrict CspA to the same cellular compartment. 
This, along with previous data showing that amino acids 46-63 can act as a functional tether for 
CspA, suggests that other mechanisms besides tether recognition may be responsible for the 
transport of CspA across the periplasm and outer membrane. Our lab has previously shown that a 
folded conformation in calmodulin can prohibit translocation across the outer membrane (Chen 
and Zuckert, 2011). In addition, our data has suggested that initiation of movement across the outer 
membrane occurs via the C-terminus of surface lipoproteins. This suggests that the C-terminus 
could be important for localization, in addition to the signaling performed at the N-terminal end of 
the mature lipoprotein.  
This study limited the necessary requirements for proper localization of CspA to the +2 through 
+5 amino acids. Additionally, this research shows that, in the case of CspA and the OspA 
subsurface mutants, the localization of one tether does not determine the localization of the same 
37 
 
tether attached to another protein (Figure 8). While many mutants capable of being trapped within 
the periplasm were made, introduction of the trapping mechanism proved deleterious in two 
separate systems. This shows that functioning lipoprotein transport is a vital part of Borrelia 
burgdorferi (Figures 9 and 10).  
9. Future Studies 
While this study was successful in limiting the minimally required tether length for export of CspA 
to the surface to the first four amino acids following the +1 cysteine, no mutations of the first four 
amino acids of the CspA tether have been placed into Borrelia. A mutational analysis of these 
amino acids could prove to be informative. Previously, deletion of the whole tether seemed to 
cause degradation of the CspA gene, or at least ablates detection with an antibody (unpublished 
data). Interestingly, the tethers that produces a surface or subsurface OspA prevent detection by 
CspA monoclonal antibodies when fused to CspA (likely due to epitope obfuscation) and do not 
prevent movement of CspA to the surface. This suggests either multiple mechanisms of transport 
are at play, or some signal is hidden in the combination of the OspA tether and CspA functional 
fold. Clearly, more research is required to approach the problem of what is necessary and required 
for lipoprotein sorting signals and their proper localization. Alongside this research, our lab has 
recently published a paper cataloging the surface localization of all the lipoproteins in B. 
burgdorferi (Dowdell et al, 2017), and no strong consensus sequence was found. Since all of the 
sequences of these proteins are known, hypotheses regarding consensus sequences can be better 
informed in future studies. While we were currently unable to make a subsurface CspA mutant, 
the elucidative power of such a mutant prevents us from immediately abandoning the attempt to 
create it. From the data provided in the paper above, I hypothesize a mutation of the +3 amino acid 
residue to serine or threonine would create a subsurface mutant. Additionally, because the naturally 
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occurring subsurface lipoprotein tether sequences are now known, I would perform a tether swap 
with these tethers in a similar manner to what was done with the OspA subsurface mutant. If we 
are successful in making a subsurface mutant CspA, the suppressor screen described above would 
be the next logical step. 
On the subject of trapping the lipoprotein within the outer membrane, an ever present concern is 
the possibility of the trapping conditions being toxic to the bacteria. Calmodulin and CBP showed 
no apparent toxicity in E. coli. Since the CaM-CBP system of entrapment is completely foreign to 
Borrelia, the risk of toxicity is low. Nevertheless, it is concerning that no viable Borrelia were 
recovered upon transformation of the suicide plasmid without a CBP protein present. Creation of 
the tet-inducible calmodulin suicide plasmid was one attempt at mitigating such toxicity during 
growth. After sufficient number of cells have grown, we would be able to study the effects of the 
entrapment using the inducible promoter. Also, because we know that a subsurface calmodulin is 
negligibly toxic (Chen and Zuckert, 2011), a redesign of the suicide plasmid’s homologous 
recombination site may be called fo  to bring this system to a place where calmodulin can be 
introduced into Borrelia’s genome. This would allow for the sorting of the OspA:CBP fusion to 
be studied without risk of toxicity during the transformation process. When it comes to LysM 
binding peptidoglycan, the toxicity of the system readily displays itself in E. coli. The introduction 
of an inducible promoter for the LysM:OspA:mRrp gene is the next logical step in addressing the 






10. Materials and Methods 
Bacterial Strains and Culture Conditions.  
The E. coli Top10 strain (Invitrogen) was the strain used for all recombinant DNA construction 
and recovery. E. coli strains were grown in Luria Bertani (LB) broth/agar (Difco). Frozen stocks 
of E. coli clones were made using 15% glycerol (v/v) into LB broth and kept at -80°C. The Borrelia 
burgdorferi strains B31-e2 and B313 are clones of the type strain B31 and were used for the 
expression of recombinant plasmids. B31-e2 expresses the linear plasmid lp54 which contains the 
genes encoding OspA and CspA. B313 lacks lp54. Both Borrelia strains were grown in BSK-II 
liquid/solid media. Frozen stocks of B. burgdorferi clones were made using 10% DMSO (v/v) into 
1x BSK-II complete. 
SDS PAGE and Immunostaining.  
Protein samples were separated using a 10% polyacrylamide gel. Initial protein visualization was 
performed using Coomassie blue staining. If needed protein levels were balanced through visual 
inspection before nitrocellulose transfer and immunostaining. Transfer of proteins from 
polyacrylamide gels to nitrocellulose membranes was completed using the Transblot-SD Semi-dry 
Transfer Cell (BioRad). After blocking with either a 5% milk solution or a 2.5% BSA solution, 
primary antibodies in blocking solution were applied to the nitrocellulose membrane for one hour 
at room temperature (RT) or overnight at 4° C. Membranes were then washed with 1x TBS-T, 
.05% Tween-20. After washing, secondary antibodies conjugated with alkaline phosphatase in 
blocking solution were added to the membranes and allowed to incubate for 1 hour at RT.  The 
membranes were then washed with TBS, incubated for 10 minutes at RT with Lumiphos WB 
(Thermo Scientific) and visualized in 30 second exposures up to 10 minutes. 
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PCR, Agarose Gel Electrophoresis, and Sequencing.  
Polymerase chain reactions were performed with either Taq polymerase or Q5 high fidelity 
polymerase according manufacturer recommended protocols. Overlap extension primers were 
design with a melting temperature (Tm) of 55° C. See Table 2 for individual primer molecules 
used. TAQ polymerase was use in 1x ThermoPol buffer, 0.2 mM primers, 0.2 mM dNTPs and 
~1ng/mL template. Q5 polymerase was used in 1x Q5 buffer, 0.5 mM primers, 0.3mM dNTPs, 
and ~1ng/uL template. Agarose gels were made between 0.75% and 1.25% (agarose type) in 1x 
TAE buffer to separate DNA by size. DNA samples were placed in the gel matrix and subjected 
to a 100V, 400 mA current for 30 to 45 minutes depending on predicted DNA size. Sample were 
visualized using ethidium bromide staining. Sequencing results were obtained by Eton 
Biosciences, Inc. and ACTG Inc. 
Plasmid Construction and Lipoprotein Mutations.  
CspA tether mutations were made in two separate PCR reactions. The first reaction was to create 
an overlap as well as add a BamH1 site beyond the 5’ end of the promoter region and HindIII site 
at the 3’ end of gene. The second reaction merged the two ends of the gene. Upon restriction these 
mutated CspA genes were ligated into the pKSSF1 shuttle vector and were confirmed by 
sequencing. See the primer list and plasmid list for additional construction details (Table 1 and 2). 
For his-tag addition an elongated 3’ primer with a poly-glycine buffer region, a 6 histidine tag with 
a stop codon and a HindIII restriction site were used with the 5’ BamH1 primer. After PCR 
amplification, an additional amplification step with Taq polymerase was used to create a 3’ adenine 
overhang that was inserted in to the TOPO TA vector. Upon insertion and amplification on E. coli 
the gene was restricted and ligated into pKSSF1 and confirmed by sequencing. OspA:CBP were 
created using Gibson assembly. Primers were designed to create overlaps with a Tm of 48°C 
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between the 3 segments to create a pBSV2 backbone, CBP tag, and OspA under the Pflab 
promoter. A subsurface CaM under a tetracycline inducible promoter was then added to these 
genes as well as a wild type OspA control. These genes were confirmed by sequencing. The 
OspA:mRfp:LysM hybrid was made using two segments. A surface localizing (native OspA) 
tether was fused to mRfp under control of the Pflab promoter, and a 5’ HindIII site was fused with 
a native 6 repeating LysM domain structure from the chromosomal Borrelia gene BB0323 
containing with the primer adding a 3’ BamH1 site. This gene was placed in pBSV2.2 which 
contains a gentamycin resistance cassette instead of kanamycin resistance found on pBSV2. 
Proteinase K Assay. 
 12 ml Borrelia cultures were grown to a concentration of 1.0 x 108 cells/ml. Cultures were split in 
half and centrifuged at 3000xG. After multiple washes to remove excess protein and a final 
resuspension with 100µl of sterile PBS plus 10mM Mg2+, 25µl of either PBS plus 10mM Mg2+ 
(control) or 25µl of Proteinase K (Invitrogen) was added to a final concentration 200µg/ml. A final 
concentration of 5mM PMSF was added to stop the reaction and inhibit any other protease activity. 
After multiple washes in PBS plus 10mM Mg2, the sample is boiled in 1x SDS loading buffer for 
5 minutes. Samples were first normalized using Coomassie stained SDS PAGE gels and then 
normalized with a western blot to FlaB.  
  
Buffer list 
BSK2 2x Incomplete  
BSK2 1x Complete 
BSK2 2x Complete 
50x TAE buffer- 242g/L Tris base, 57.1mL/L Glacial acetic acid, 100ml/L 0.5M EDTA (pH 8.0) 
Polyacrylamide gel running buffer- 100mL/L 10x TG Buffer, 5ml/L 20% SDS 
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Nitrocellulose transfer buffer- 100mL/L 10x TG Buffer, 
10x PBS- 80g/L NaCl, 2g/L KCl, 14.4g/L Na2HPO4, 2.4g/L KH2PO4 
10x dPBS- 80g/L NaCl, 2g/L KCl, 11.5g/L Na2HPO4, 2.0g/L KH2PO4 
EPS- 93g/L sucrose, 15% (v/v) glycerol 
10x TG Buffer- 188g/L glycine, 30.2g/L Tris base 
2x SDS Loading Buffer- 100mM Tris-Cl (pH 6.8), 4% (w/v) SDS, 0.2% (w/v) bromphenol blue, 20% (v/v) 
glycerol 
6x DNA Loading Buffer- .25% (w/v) bromphenol blue, .25% (w/v) xylene cyanol FF, 30% (v/v) glycerol 
10x TBS- 80g/L NaCl, 2g/L KCl, 30g/L Tris Base pH 7.4 
10x TE- 100mM Tris-Cl, 10mM EDTA 
Resolving Gel Buffer- 181.7g/L Tris base, 4g/L SDS pH 8.8 




Table 1. Plasmid List 
Plasmid 
Name 
Plasmid Origin Antibiotic 
Marker(s) 
Gene Description 
pCspA pKSSF1 SPC/STR CspA 
pOSK323 pCspA SPC/STR CspA tether missins amino acids 26-45 
pOSK324 pCspA SPC/STR CspA tether missing amino acids 46-63 
pJE1100 pOSK324 SPC/STR CspA tether missing amino acids 42-63 
pJE1101 pOSK324 SPC/STR CspA tether missing amino acids 38-63 
pJE1102 pOSK324 SPC/STR CspA tether missing amino acids 34-63 
pJE1103 pOSK324 SPC/STR CspA tether missing amino acids 30-63 
pJE1103h pJE1103 SPC/STR CspA tether missing amino acids 30-63 with 
a his tag 
pJE1150 pRJS1009&pOSK324 SPC/STR CspA w/OspA(wt) tether 
pJE1150h pRJS1009&pOSK324 SPC/STR CspA w/OspA(wt) tether with a his tag 
pJE1151 pRJS1089&pOSK324 SPC/STR CspA w/OspA(dv21) tether 
pJE1151h pRJS1089&pOSK324 SPC/STR CspA w/OspA(dv21) tether with a his tag 
    
pRJS1098 pBSV2 KAN OspA under constituative promoter 
pJEctc pRJS1098 KAN OspA with C terminal cbp Tag 
pJEctn pRJS1098 KAN OspA with N terminal cbp Tag 
pJECCam pJEctc & pSCv21x KAN OspA with C terminal cbp Tag and tet 
inducible CaM 
pJENCam pJEctn & pSCv21x KAN OspA with N terminal cbp Tag and tet 
inducible CaM 
pJEWTCam pRJS1098 & pSCv21x KAN WT OspA with tet inducible dv21 Cam 
pJETPCam pSCv21x & pXLF14301 KAN homologous rec. with tet inducible dv21 
Cam 
    
pRJS1009 pBSV2 KAN Surface localizing RFP 
pRJS1089 pBSV2 KAN Subsurface localizing RFP 
pJElysm pRJS1009&LysM&pBS
V2.2 






Table 2. Primer List 
Primer Name Primer Sequence 
GL _tetR-rev 5’- GTGAAAGTGGGTCTTAATGAGGTACCGTAATCATGGTCATAGCTG -3’ 
GL _tetR-fwd 5’- TCATTAAGACCCACTTTCACATTTAAGTTG -3’ 
GR_Post-rev 5’- AAGTCCCAAAACTGGGACTTTTTTTAAATAAAAAAT -3’ 
GR_PflaB-fwd 5’- TCCCAGTTTTGGGACTGGGATCCTGTCTGTCGCCTCTTGTGGC -3’ 
G_OspA_CBPtag_C-fwd 5’-GTTTCTGCAGCTAATAGATTTAAGAAAATTTCTTCAAGTGGAGCTTTAT 
AATCTAGAGTCGACCTGCAGGCATG CAAGCTTGGCACTGGC -3’ 
G_OspA_CBPtag_C-rev 5’- TCTATTAGCTGCAGAAACAGCAATAAAATTCTTTTTCCACCTTCTTTTA 
GC ACCTGATCCACCAGGTTTTAAAGC GTTTTTAATTTCATC -3’ 
G_OspA_CBPtag_N-fwd 5’- GCAGCTAATAGATTTAAGAAAATTTCTTCAAGTGGAGCTTTACCTG 
GTG GATCAGGTGCTAGCGTTTCAGTAGA TTTGCCTGGTGAAATG -3’ 
G_OspA_CBPtag_N-rev 5’- TGAAGAAATTTTCTTAAATCTATTAGCTGCAGAAACAGCAATAAAATTC 
TTTTTCCACCTTCTTTTGTTTTTCTCG TCAAGGCTGCTAAC -3’ 
GL_OspA_CBPtagII-rev 5’- ACACTGATCCACCAGGGCTTTTAATTCCTGTGTATTCAAGTC -3’ 
GL_linkerCBPtag-fwd 5’- CCTGGTGGATCAGGTGCTAAAAGAAG -3’ 
GR_CBPtagII_OspA-fwd 5’- CCTGGTGGATCAGGTGCTGATGGATCTGGAAAAGCTAAAGAG -3’ 
GL_OspA_CBPtagI-rev 5’- CACCTGATCCACCAGGTTTGGAAGTTACTTTTTTTGATAC -3’ 
GR_CBPtagI_OspA-rev 5’- AGCACCTGATCCACCAGGTAAAGCTCCACTTGAAGAAATTTTC -3’ 
GR_CBPtagI_OspA-fwd 5’- TGGTGGATCAGGTGCTGACAAGTCATCAACAGAAGAAAAATT -3’ 
SOE OSPAwtTethCspa-fwd 5’- GTTAGCAGCCTTGACGAGAAAAACAGCTGTGATGAAAAAATTATGG 
AAAC -3’ 
SOE OspA21xTethCspa-fwd 5’- GCAGCCTTGACGAGAAAAACAGCTCTGATGAAAAAATTATGGAAACT 
ATCG -3’ 
SOE CspA_OspAwtteth-rev 5’- CTCGTCAAGGCTGCTAACATTTTGCTTGCATGAGGTGCAAATTAAAGT 
TAAAGTTAATATC -3’ 
SOE CspA_OspA21xteth-rev 5’- CTCGTCAAGGCTGCTATTTTGCTTGCATGAGGTGCAAATTAAAGTTAA 
TATC- 3’ 
pBSV2_5'Hind-fwd 5’- ACGTTCTAAAACGACGGCCAGTGC -3’ 
pBSV2_3'MCS-rev 5’- ACACTTTATGCTTCCGGCTC -3’ 
SOE-CspA_30-63_fwd 5’-CCTCATGCGCACCTTTTAGCTCTGATGAAAAAATTATGGAAAC-3’ 
SOE-CspA_34-63_fwd 5’-GCACCTTTTAGCAAAATCGATCCTTCTGATGAAAAAATTATGGAAAC-3’ 
SOE-CspA_38-63_fwd 5’- CGATCCTAAAGCAAATGCATCTGATGAAAAAATTATGGAAAC-3’ 
SOE-CspA_42-63_fwd 5’- GCAAATGCAAACACTAAGCCATCTGATGAAAAAATTATGGAA AC -3’ 
SOE-CspA_30-63_rev 5’- CCATAATTTTTTCATCAGAGCTAAAAGGTGCGCATGAGG -3’ 
SOE-CspA_34-63_rev 5’-CCATAATTTTTTCATCAGAAGGATCGATTTTGCTAAAAGGTGC-3’ 
SOE-CspA_38-63_rev 5’- CCATAATTTTTTCATCAGATGCATTTGCTTTAGGATGATCG -3’ 
SOE-CspA_42-63_rev 5’- CCATAATTTTTTCATCAGATGGCTTAGTGTTTGCATTTGC -3’ 
SOE-CspA_his_fwd 5’- CAGGTGCTCATCATCATCACCATCATTAATAGAAAGAAAAAAA 
ATAATATGTTG -3’ 





BamCspAHis_rev 5’- GCGGATCCTTAATGATGGTGATGATGATGAGCACCTGAGCCCCCGGG 
GTAAAAGGCAGGTTTTAAAG -3’ 
BampostXLF14301_fwd 5’- GACGCGGATCCGCGTCGGGCAATTCCACCACACTGGACTAG -3’ 
Bampost_rev 5’- GACGCGGATCCGCGTCCTGGGACTTTTTTTAAATAAAAAATCTAC- 3’ 
Not1tetRXLF14301_rev 5’- GGGAACGTTGCGGCCGCAACGTTCCCTACCCGAGCTTCAAGGAA 
GATTTCC -3’ 
Not1tetR_fwd 5’- GGGAACGTTGCGGCCGCAACGTTCCCTCATTAAGACCCACTTTCACA 
TTTAAG -3’ 
mrfp1-lysM-rev 5’- AGCACCTGAGCCACCCGGGGCGCCGGTGGAG -3’ 
mrfp1-lysM-fwd 5’- CCGGGTGGCTCAGGTGCTGTAATAAAAATAGGCAATACCCTATG -3’ 
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